Comparing the Effects of Anti-TNF Agent and Ustekinumab on Small Bowel Inflammation in Crohn's Disease: Inverse Probability Weighting With Stabilized Weights of Propensity Scores.
Yuki HirataDaisuke NishiokaKoji NishidaHikaru ShimizuNoboru MizutaKeijiro NumaKei NakazawaKazuki KakimotoTakako MiyazakiShiro NakamuraHiroki NishikawaPublished in: Crohn's & colitis 360 (2024)
This study suggests that UST might be more effective than anti-TNF-α agents in treating small intestinal inflammation in Crohn's disease.